Participated · Series A · Jul 2026

Throne Science makes a discreet sensor that attaches to standard toilets and, combined with an AI-powered companion app, passively tracks bathroom habits to surface patterns in digestive health, hydration status, and urinary function. The company was founded in 2023, is based in Austin, Texas, and launched to consumers in March 2026. In July it introduced a beta Gut Health AI coach that lets users ask questions about their gut health data and receive personalized feedback. Throne has hired leaders from consumer wearable and health tech companies and added medical advisors and a chief of science to its team. Financially, Throne announced a $10 million Series A to support personnel growth and R&D. Its stated long-term mission is to develop the technology into a home-based continuous screener for early signs of colorectal cancer and cancers of the urinary tract.

Participated · Series A · May 2026

Dandelion Health develops a multimodal clinical AI platform intended to inform drug development and redesign clinical trial design using high-fidelity longitudinal clinical data. The company positions its platform to better characterize pre-disease windows and patient trajectories so trials are built against current clinical realities rather than outdated disease definitions. Leadership mentioned in the announcement includes Elliott Green and Niyum Gandhi, and the company has attracted investors with healthcare and scientific expertise. Financially, the company completed a $14 million Series A led by new investors Healthier Capital and Colle Capital alongside returning investors Primary Venture Partners, Moxxie Ventures, and Convergent Ventures. Dandelion says the new capital will be applied to continue developing its clinical-AI capabilities and expanding its platform's use in life sciences and AI development. The article does not disclose revenue, user, or other operating metrics.

Led · Seed · Feb 2026

Orange Slice builds an AI tool that lets salespeople and sales engineers generate prospecting spreadsheets simply by typing natural-language prompts. The software pulls real-time data from across the web to surface high-value leads, addressing what the founders see as sales’ core pain point: knowing whom to contact, not what to say. The product is sold on a subscription basis and is already in use by fellow Y Combinator companies Novoflow and Pirros. Cofounded by recent University of Michigan graduates Vihaar Nandigala (CEO) and Kishan Sripada (CTO), Orange Slice emerged from Y Combinator’s startup program. With fresh capital in hand, the company plans to expand its engineering team to accelerate product development. The company recently secured $5.3 million in seed funding, providing a meaningful runway for growth and customer acquisition.

Participated · Seed · Jan 2026

Phoebe is developing a self-driving infrastructure for America’s home-health market, beginning with mission-critical scheduling software that eliminates logistical chaos for agencies, nurses, caregivers, and families. The platform automates back-office tasks so care teams can devote more time to patients rather than administrative work. Early customers—including industry operators such as Bob Conley, Max Martinolich, Tiffany Phelan, Jeff Rigler, and Tyler Kelly—are already collaborating closely with the company. Phoebe aspires to become the operating backbone of home healthcare and plans to broaden its automation toolkit as it scales through 2026. Headquartered in New York City, the startup is actively hiring across engineering, sales, and business-operations roles to accelerate growth. Backed by a fresh $9.5 million seed round, Phoebe now has additional runway to expand product capabilities and customer adoption. The company has not yet disclosed specific revenue or user figures.

Participated · Seed · Dec 2025

Ridley offers a step-by-step, AI-driven platform that helps homeowners list, market, and sell properties without paying traditional agent commissions. The Newark, Delaware-based company distributes listings to major home-buying sites, provides on-demand legal support and concierge services, and connects users with Ridley Preferred Agents for expert help. It plans to launch a buy-side experience that grants buyers access to private listings, active for-sale homes, and ‘soon-to-be-listed’ properties surfaced by predictive analytics. Since its July 15 launch, Ridley has generated more than $4.6 billion in lead volume, accumulated over $350 million in private listings, and facilitated 57 home sales that averaged 33 days on market with a 98.3% list-to-sold ratio. These early metrics underscore consumer interest in a commission-free, data-driven model. The new capital positions the startup to deepen its proprietary AI capabilities for both sellers and buyers while expanding its network of commission-free agents. Ridley remains at the seed stage with $6.4 million in total funding raised to date.